€10.08
0.15% today
Madrid, Sep 19, 05:35 pm CET
ISIN
ES0171996087
Symbol
GRF
Sector
Industry

Grifols Stock price

€10.06
+1.36 15.66% 1M
+2.57 34.35% 6M
-5.40 34.91% YTD
-2.98 22.85% 1Y
-12.14 54.68% 3Y
-17.33 63.27% 5Y
-6.44 39.03% 10Y
Madrid, Closing price Wed, Sep 18 2024
-0.21 2.00%
ISIN
ES0171996087
Symbol
GRF
Sector
Industry

Key metrics

Market capitalization €6.84b
Enterprise Value €18.07b
P/E (TTM) P/E ratio 43.49
EV/Sales (TTM) EV/Sales 2.75
P/S ratio (TTM) P/S ratio 1.04
P/B ratio (TTM) P/B ratio 1.22
Revenue (TTM) Revenue €6.57b
EBIT (operating result TTM) EBIT €857.73m
Cash position €2.11b
EPS (TTM) EPS €0.23
P/E forward 19.47
P/S forward 0.97
EV/Sales forward 2.55
Show more

Is Grifols a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Grifols Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Grifols forecast:

9x Buy
64%
4x Hold
29%
1x Sell
7%

Analyst Opinions

14 Analysts have issued a Grifols forecast:

Buy
64%
Hold
29%
Sell
7%

Financial data from Grifols

Assets
Jun '24
6,915 6,915
Cash 2,113 2,113
Claims 935 935
Inventories 3,623 3,623
Other current assets Other current assets Current assets 243 243
15,377 15,377
Property, plant and equipment 4,215 4,215
Financial assets 705 705
Intangible Assets 9,983 9,983
Other fixed assets Other assets Fixed assets 474 474
Total Assets 22,291 22,291
Liabilities
Jun '24
Equity 8,295 8,295
13,982 13,982
Current liabilities 4,112 4,112
Non-current liabilities 9,870 9,870
Total Capital 22,278 22,278

In millions EUR.

Don't miss a Thing! We will send you all news about Grifols directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Head office Spain
CEO Nacho Abia
Employees 23,744
Founded 1940
Website www.grifols.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today